falsefalse

Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLC - Episode 2

Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023

Dr. Eduardo Santos, MD, FACP, FCCP, highlights advancements in neoadjuvant immunotherapy for NSCLC presented during key conferences in 2023, underscoring pivotal findings and the potential transformation of treatment approaches.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Immunotherapy-Based Strategies for NSCLC in the Neoadjuvant/Perioperative Setting
    Now Viewing
    EP. 2: Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023
    EP. 3: Updates in Adjuvant Immunotherapy for NSCLC: Conference Highlights 2023
    EP. 4: Immunotherapy-Based Treatment Strategies in Advanced NSCLC
    EP. 5: EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC
    EP. 6: Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials
    EP. 7: Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023
    EP. 8: NSCLC 2023 Data Updates: Shaping the Future Treatment Landscape

    Related Content:

    Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLCVideo SeriesInsights Video SeriesInsightsLung Cancer
    Obrixtamig Could Broaden the Reach of DLL3/CD3-Targeted BiTEs in Small Cell Lung and Other Neuroendocrine Cancers
    Targeted Therapy Developments and Screening Updates Broaden the NSCLC Treatment Paradigm
    Maximizing Patient Outcomes for IO Sequencing in Advanced EC
    x